Clinical Trial

Early Atrial Fibrillation Ablation for Stroke Prevention in Patients With High Comorbidity Burden (EASThigh-AFNET 11)

Recruiting
View on ClinicalTrials.gov →
Summary
EASThigh-AFNET 11 is an international, prospective, randomized, open, blinded endpoint assessment, multicenter trial (Treatment Strategy trial). The objective of EASThigh-AFNET 11 is to investigate whether early atrial fibrillation ablation in patients with atrial fibrillation (AF) and a high comorbidity burden (CHA2DS2-VASc ≥4) reduces cardiovascular events (stroke, cardiovascular death, or heart failure events) compared to usual care.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-03-19; most recent amendment 2026-01-06.
Status change: Not Yet Recruiting → Recruiting 2024-10-15
Trial Details
NCT Number NCT06324188
Lead Sponsor Atrial Fibrillation Network
Conditions Atrial Fibrillation
Enrollment 2,312 participants
Start Date 2024-10-14
Primary Completion 2030-02 (estimated)
Study Completion 2030-05 (estimated)
Updated on ClinicalTrials.gov 2026-01-08